Disease or SyndromeENTITYORG Beacon’s rare eye disease gene therapy signals vision function improvements in early phase 2 data 2 days ago talkbio0Tagged DAWN, Disorder of eye, gene therapy, laru-zova, Phase 2 trial, Vision, XLRP Beacon's Gene Therapy Shows Promise for Rare Eye Disease Sources: